Adverse drug event profile of pharmacotherapies for alcohol use disorder: a retrospective pharmacovigilance disproportionality analysis study

The study underscores the diverse AEPs of these medications, highlighting the need for careful monitoring and individualized treatment to ensure safety and efficacy in managing AUD.

Authors

Institutions

Publication Details

Journal
Expert Opinion on Drug Safety
Published
2025-02-07
DOI
https://doi.org/10.1080/14740338.2025.2464896
Citations
2
Primary Topic
Opioid Use Disorder Treatment
Type
article
Field-Weighted Citation Impact
3.76
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Adverse drug event profile of pharmacotherapies for alcohol use disorder: a retrospective pharmacovigilance disproportionality analysis study

Kannan Sridharan
2 citations
Expert Opinion on Drug Safety
Opioid Use Disorder Treatment
3.76
article

Adverse drug event profile of pharmacotherapies for alcohol use disorder: a retrospective pharmacovigilance disproportionality analysis study

Kannan Sridharan
article en
2 citations

Abstract

The study underscores the diverse AEPs of these medications, highlighting the need for careful monitoring and individualized treatment to ensure safety and efficacy in managing AUD.

Expert Opinion on Drug Safety
Arabian Gulf University (BH)
Good health and well-being
Openalex Percentile: Top 9%
Opioid Use Disorder Treatment
3.76
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Adverse drug event profile of pharmacotherapies for alcohol use disorder: a retrospective pharmacovigilance disproportionality analysis study — Kannan Sridharan · Expert Opinion on Drug Safety (2025) | TGRS Research Map | TGRS